Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Bioinformatics Unit, Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia.
Cell Rep. 2021 Dec 7;37(10):110088. doi: 10.1016/j.celrep.2021.110088.
Alternative lengthening of telomeres (ALT) is a telomere-elongation mechanism observed in ∼15% of cancer subtypes. Current models indicate that ALT is mediated by homology-directed repair mechanisms. By disrupting MSH6 gene expression, we show that the deficiency of MutSα (MSH2/MSH6) DNA mismatch repair complex causes striking telomere hyperextension. Mechanistically, we show MutSα is specifically recruited to telomeres in ALT cells by associating with the proliferating-cell nuclear antigen (PCNA) subunit of the ALT telomere replisome. We also provide evidence that MutSα counteracts Bloom (BLM) helicase, which adopts a crucial role in stabilizing hyper-extended telomeres and maintaining the survival of MutSα-deficient ALT cancer cells. Lastly, we propose a model in which MutSα deficiency impairs heteroduplex rejection, leading to premature initiation of telomere DNA synthesis that coincides with an accumulation of telomere variant repeats (TVRs). These findings provide evidence that the MutSα DNA mismatch repair complex acts to restrain unwarranted ALT.
端粒的非经典延长(ALT)是在约 15%的癌症亚型中观察到的一种端粒延长机制。目前的模型表明,ALT 是由同源重组修复机制介导的。通过破坏 MSH6 基因的表达,我们表明 MutSα(MSH2/MSH6)错配修复复合物的缺乏导致端粒明显的过度延伸。从机制上讲,我们发现 MutSα 通过与 ALT 端粒复制体的增殖细胞核抗原(PCNA)亚基结合,特异性地被招募到 ALT 细胞的端粒上。我们还提供了证据表明 MutSα 可以拮抗 Bloom(BLM)解旋酶,该酶在稳定过度延伸的端粒和维持 MutSα 缺陷的 ALT 癌细胞的存活中起着至关重要的作用。最后,我们提出了一个模型,其中 MutSα 的缺乏会损害异源双链体的排斥,导致端粒 DNA 合成的过早起始,同时伴随着端粒变异重复(TVR)的积累。这些发现提供了证据表明 MutSα DNA 错配修复复合物可以抑制不必要的 ALT。
Cancers (Basel). 2025-7-9
Cell Biosci. 2025-3-1
Front Pharmacol. 2024-6-7
Int J Mol Sci. 2023-12-18
FEBS Open Bio. 2023-9
Nat Commun. 2021-3-10
Cell Rep. 2020-10-20
Nat Struct Mol Biol. 2020-12
Genes Dev. 2020-10-1
Trends Cancer. 2020-3
Nature. 2020-2-5